herpes

News

Aicuris acquisition delivers new drug for Asahi Kasei

Asahi Kasei's $920m takeover of Germany's Aicuris in April has paid off with FDA approval for the herpes simplex virus drug at the heart of the deal.

News

Herpes simplex virus (HSV-2) capsid visualisation

GSK drops HSV jab, leaving rival mRNA shots in pole position

GSK has abandoned its clinical-stage vaccine for herpes simplex virus (HSV) after a disappointing phase 1/2 trial, ceding the ground to mRNA shots in development at Moderna and BioNTech.

News

Herpes_infection_on_ThinPrep_Pap_smear_(4131420362)

Herpes virus discoveries could lead to new drugs

Researchers have discovered the biological mechanisms that the herpes virus uses to infect people, potentially leading to a new generation of drug therapies.

Aicuris acquisition delivers new drug for Asahi Kasei

GSK drops HSV jab, leaving rival mRNA shots in pole position

Herpes virus discoveries could lead to new drugs

GSK planning 1,200 job cuts in Belgium, says paper

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks